SpectraCure
2.755
SEK
-18.25 %
SPEC
First North Stockholm
Medical Equipment & Services
Health Care
3 following
-18.25%
+72.62%
+25.23%
+15.76%
-28.63%
-29.99%
-53.66%
-89.37%
+87.74%
SpectraCure is a medical technology company The company specializes in the research and development of medical technology systems used to treat prostate cancer. The cancer treatments are based on proprietary systems that emit laser light sources and photoreactive drugs, a treatment methodology used for internally solid tumors of various types. The company operates in the Nordic market. The head office is located in Lund.
Read moreMarket cap
267.6M SEK
Turnover
1.67M SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
20/2
2025
Annual report '24
15/5
2025
Interim report Q1'25
15/8
2025
Interim report Q2'25
ShowingAll content types
Ordförande i SpectraCure ökar sitt innehav
SpectraCure har tecknat avtal med sjukhus i New York om klinisk studie för primär lokaliserad prostatacancer
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools